United Therapeutics (UTHR) Total Debt (2017 - 2025)
Historic Total Debt for United Therapeutics (UTHR) over the last 14 years, with Q1 2025 value amounting to $200.0 million.
- United Therapeutics' Total Debt fell 6666.67% to $200.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $200.0 million, marking a year-over-year decrease of 6666.67%. This contributed to the annual value of $300.0 million for FY2024, which is 5714.29% down from last year.
- According to the latest figures from Q1 2025, United Therapeutics' Total Debt is $200.0 million, which was down 6666.67% from $300.0 million recorded in Q4 2024.
- In the past 5 years, United Therapeutics' Total Debt registered a high of $800.0 million during Q1 2021, and its lowest value of $200.0 million during Q1 2025.
- In the last 5 years, United Therapeutics' Total Debt had a median value of $800.0 million in 2021 and averaged $676.5 million.
- In the last 5 years, United Therapeutics' Total Debt changed by 0.0% in 2021 and then tumbled by 6666.67% in 2025.
- Over the past 5 years, United Therapeutics' Total Debt (Quarter) stood at $800.0 million in 2021, then changed by 0.0% to $800.0 million in 2022, then dropped by 12.5% to $700.0 million in 2023, then tumbled by 57.14% to $300.0 million in 2024, then plummeted by 33.33% to $200.0 million in 2025.
- Its Total Debt was $200.0 million in Q1 2025, compared to $300.0 million in Q4 2024 and $400.0 million in Q3 2024.